Parkinson's disease/Site map

Each line in the hierarchical Site Map below is in two parts:

The link text as it usually appears in the text and
The link to the page or subpage with its full Wikiversity name.

The User Guide for this Wikiversity learning project is at PD_Wiki_User_Guide

edit

The Science Behind Parkinson's - Portal:The_Science_Behind_Parkinson's

edit
> Project Development - Portal:The_Science_Behind_Parkinson's/Project_Development
> The six purposes of Section 1 - Portal:The_Science_Behind_Parkinson's/Section 1/more

> Section 1: Progress and Prospects in Parkinson's Research - Progress_and_Prospects_in_Parkinson's_Research

edit
> > - Magazine Section - PD_Magazine_Section
edit
> Getting the ball rolling - PD_Magazine_Section/Getting_the_ball_rolling
> Hot Topics - PD_Hot_Topics
> Vitamin D - Deficiencies_as_PD_cause/Vitamin_D
> Role of alpha-synuclein in pathogenesis - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein
> Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents
> Biomarkers and Biomeasures - Monitoring_Parkinson's_Disease
> Induced Pluripotent Stem Cells - Modelling_PD/iPSC
> Genome-Wide Association Studies - PD_Inheritance/GWAS
> Getting Drugs from Lab to Clinic - PD_Research_to_clinic
> > - Researching Parkinson's - Researching_Parkinson's
edit
> Modelling Parkinson's - Modelling_PD
> Animal Models - Modelling_PD/Animal_Models
> Rotenone Model - Modelling_PD/Rotenone PD Model
> Induced Pluripotent Stem Cells - Modelling_PD/iPSC
> Hot Topics - PD_Hot_Topics
> Vitamin D - Deficiencies_as_PD_cause/Vitamin_D
> Role of alpha-synuclein in pathogenesis - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein
> Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents
> Biomarkers and Biomeasures - Monitoring_Parkinson's_Disease
> Induced Pluripotent Stem Cells - Modelling_PD/iPSC
> Genome-Wide Association Studies - PD_Inheritance/GWAS
> Getting Drugs from Lab to Clinic - PD_Research_to_clinic
> > - Causes - PD_Causes
edit
> Inheritance - PD_Inheritance
> SNCA - PD_Inheritance/SNCA
> LRRK2 - PD_Inheritance/LRRK2
> MAPT - PD_Inheritance/MAPT
> GBA - PD_Inheritance/GBA
> HLA - PD_Inheritance/HLA
> Trauma - Trauma as PD Cause
> Infection - Infection_as_PD_cause
> Melanoma - Infection_as_PD_cause/Melanoma
> Whooping cough - Infection_as_PD_cause/Whooping cough
> Helicobacter - Infection_as_PD_cause/Helicobacter_pylorii
> Deficiencies
> Blood - Deficiencies_as_PD_cause/Blood
> Glutathione - Deficiencies_as_PD_cause/Glutathione
> Melatonin - Deficiencies_as_PD_cause/Melatonin
> Norepinephrine - Deficiencies_as_PD_cause/Norepinephrine
> Vitamin D - Deficiencies_as_PD_cause/Vitamin_D
> Zinc - Deficiencies_as_PD_cause/Zinc
> Toxins - Toxins_as_PD_cause
> Cadmium - Toxins_as_PD_cause/Cadmium
> Copper - Toxins_as_PD_cause/Copper
> Dieldrin - Toxins_as_PD_cause/Dieldrin
> Manganese - Toxins_as_PD_cause/Manganese
> Maneb - Toxins_as_PD_cause/Maneb
> Mercury - Toxins_as_PD_cause/Mercury
> MPTP - Toxins_as_PD_cause/MPTP
> n-Hexane - Toxins_as_PD_cause/n-Hexane
> Paraquat - Toxins_as_PD_cause/Paraquat
> Rotenone - Toxins_as_PD_cause/Rotenone
> Toluene - Toxins_as_PD_cause/Toluene
> Trichloroethylene - Toxins_as_PD_cause/Trichloroethylene
> Ziram - Toxins_as_PD_cause/Ziram
> > - Pathogenesis - Parkinson's_Pathogenesis
edit
> Current Parkinson's Paradigm - Current_Parkinson's_Paradigm
> Working Hypothesis - Current_Parkinson's_Paradigm/Working_Hypothesis
> Emerging Hypotheses - Current_Parkinson's_Paradigm/Emerging_Hypotheses
> Oxidative Stress - Current_Parkinson's_Paradigm/Oxidative_Stress
> Role of alpha-synuclein - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein
> > - Therapy - PD_Therapy
edit
> Transplantation - Transplantation_for_PD
> Symptomatic Relief - Symptomatic Relief_for_PD
> Bradykinesia - Symptomatic Relief_for_PD/Bradykinesia
> Dyskinesia - Symptomatic Relief_for_PD/Dyskinesia
> Festination - Symptomatic Relief_for_PD/Festination
> Freezing - Symptomatic Relief_for_PD/Akinesia
> Non-motor symptoms - Symptomatic Relief_for_PD/Non-Motor
> Tremor - Symptomatic Relief_for_PD/Tremor
> Exercise - Exercise_for_PD
> Effect on symptoms - Exercise_for_PD/Effect_on_Symptoms ::::> Neuroprotective effects - Exercise_for_PD/Neuroprotective_effects
> Neuroprotection - PD_Neuroprotection
> Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents
> Caffeine - PD_Neuroprotection/Caffeine
> Celastrol - PD_Neuroprotection/Celastrol
> Co-enzyme Q10 - PD_Neuroprotection/Co-Enzyme Q10
> Creatine - PD_Neuroprotection/Creatine
> DHA - PD_Neuroprotection/DHA
> Exendin-4 (EX-4) - PD_Neuroprotection/Exendin-4 (EX-4)
> GDNF - PD_Neuroprotection/GDNF
> Glutathione (GSH) - PD_Neuroprotection/Glutathione (GSH)
> GM1 - PD_Neuroprotection/GM1
> Isradipine - PD_Neuroprotection/Isradipine
> Melatonin - PD_Neuroprotection/Melatonin
> Mirapex - PD_Neuroprotection/Mirapex
> Minocycline - PD_Neuroprotection/Minocycline
> Nicotine - PD_Neuroprotection/Nicotine
> NSAIDs - PD_Neuroprotection/NSAIDs
> Phenylbutyrate - PD_Neuroprotection/Phenylbutyrate
> Phytic Acid - PD_Neuroprotection/Phytic Acid
> Quinoxaline - PD_Neuroprotection/Quinoxaline
> Rasagiline - PD_Neuroprotection/Rasagiline
> Riboflavin - PD_Neuroprotection/Riboflavin
> Statins - PD_Neuroprotection/Statins
> Tolcapone - PD_Neuroprotection/Tolcapone
> Urate & Uric Acid - PD_Neuroprotection/Urate & Uric Acid
> Vitamin D - PD_Neuroprotection/Vitamin D
> Vitamin E - PD_Neuroprotection/Vitamin E
> From Lab to Clinic - PD_Research_to_clinic
> Clinical trials and the route to market - PD_Research_to_clinic/The route to market
> > - Monitoring Disease - Monitoring_Parkinson's_Disease
edit
> Biomarkers - Biomarkers_for_PD
> Measurement of Disease Progression - Measurement_of_Parkinson's_Disease Progression
> > - Atypical parkinsonism - Atypical_parkinsonism
edit
> MSA - Multiple_System_Atrophy
> PSP - Progressive_Supranuclear_Palsy
> DLB - Dementia_with_Lewy_Bodies
> ET - Essential Tremor
> CBD - Corticobasal_Degeneration_(CBD)

> Section 2: Introduction to Parkinson's Science - Introduction_to_Parkinson's_Science

edit
> Site Map for Section 2 - Introduction_to_Parkinson's_Science/Site_Map
> > What causes the motor symptoms? - Introduction_to_Parkinson's_Science/Q_Page_2
edit
> > Why is there not enough dopamine? - Introduction_to_Parkinson's_Science/Q_Page_3
edit